REFERENCES
- Barth, R. F., Soloway, A. H., Fairchild, R. G., and Brugger, R. M. 1992. Boron neutron capture therapy for cancer. Cancer 70:2995 – 3007.
- Barth, R. F., Yang, W., Rotaru, J. H., Moeschberger, M. L., Joel, D. D., Nawrocky,
- M. M., Goodman, J. H., and Soloway, A. H. 1997. Boron neutron capture therapy of brain tumors: enhance d survival following intracarotid injection of either sodium borocaptat e or boronophenylalanin e with or without blood- brain barrier disruption. Cancer Res. 57:1129 –1136.
- Betageri, G. V., Jenkins, S. A., and Parsons, D. L. 1993. Liposome Drug Delivery Systems, 65– 66. Lancaster, PA: Technomic Pub.
- Chen, W., He, J., Olson, J. J., and Lu, D. R. 1998. Direct intracerebral delivery of carboplatin from PLGA microsphere s against experimenta l malignant glioma in rats. Drug Del. 5:1–10.
- Chen, W., Ji, B., and Lu, D. R. 2000. Biomaterial implants for treatment of central nervous system diseases. In Biomaterials Engineering and Devices: Human Applications, vol. 1, Fundamental s and vascular and carrier application, 307– 344. Humana Press, Totowa, NJ.
- Deamer, D. W. 1978. Preparation and properties of ether injection liposomes. Ann. N.Y. Acad. Sci. 308:250 – 258.
- Hawthorne, M. F., and Shelly, K. 1997. Liposomes as drug delivery vehicles for boron agents. J. Neuro-Oncol. 33:53– 58.
- Juliano, R. L. 1981. Pharmacokinetic s of liposome-encapsulate d drugs. In Liposomes: From Physical Structure and Therapeuti c Application, ed. C. G. Knight, 391– 407. Amsterdam: Elsevier/North-Holland Biomedical Press.
- Metha, S., and Lu, D. R. 1996. Targeted drug delivery for boron neutron capture therapy. Pharm. Res. 13:344 – 351.
- Mehta, S., Olson, J., and Lu, D. R. 1995. Brain tissue reaction following in- tracerebral injection of free or liposomally encapsulated BSH. Drug Del. 2:175– 180.
- Mehta, S., Lai, J. C. K., and Lu, D. R. 1996. Liposomal formulations containing sodium mercaptoundecahydrododecaborat e (BSH) for boron neutron capture therapy. J. Microencapsul. 13:269– 279.
- Olivi, A., and Brem, H. 1994. Interstitial chemotherap y with sustained-releas e polymer systems for the treatment of malignant gliomas. In Molecular Neuro- Oncology and Its Impact on the Clinical Management of Brain Tumors, ed. O. D. Weistler, U. Schlegel, and J. Schramm, 149– 154. Berlin: Springer- Verlag.
- Soloway, A. H., Tjarks, W., Barnum, B. A., Rong, F., Barth, R. F., Codogoni, I. M., and Wilson, J. G. 1998. The chemistry of neutron capture therapy. Chem. Rev. 98:1515– 1562.
- Tolpin, E. I., Wellum, G. R., Dohan, F. C., Kornblith, P. L., and Zamenhof, R. G. 1975. Boron neutron capture therapy of cerebral gliomas: II. Utiliza- tion of the blood-brain barrier and tumor-specific antigens for the selective concentrations of boron in glioma. Oncology 32:223– 246.
- Williams, J. A., Yuan, X., Dillehay, L. E., Shastri, V. R., Brem, H., and William, J. R. 1998. Synthetic, implantable polymers for local delivery of IUDR to experimenta l human malignant glioma. Int. J. Rad. Oncol. Biol. Phys. 42:631 – 639.